How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases

MeSH terms

• Anti-Inflammatory Agents / adverse effects
• Anti-Inflammatory Agents / therapeutic use*
• Biomarkers / metabolism
• Clinical Trials as Topic / methods*
• Colitis, Ulcerative / diagnosis
• Colitis, Ulcerative / drug therapy*
• Colitis, Ulcerative / metabolism
• Crohn Disease / diagnosis
• Crohn Disease / drug therapy*
• Crohn Disease / metabolism
• Drug Discovery / methods*
• Endpoint Determination
• Gastrointestinal Agents / adverse effects
• Gastrointestinal Agents / therapeutic use*
• Humans
• Patient Selection
• Predictive Value of Tests
• Research Design*
• Treatment Failure